SCHEMBL2812017

SCHEMBL2812017

COc1cc(OC)nc(CN2CCN(c3nc4c5c(n3)N(Cc3ccccc3)CCC5NN4)CC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 9/20 0.38
DNMT3A Q9Y6K1 5/20 0.38
NSD2 O96028 3/20 0.38
NSD3 Q9BZ95 3/20 0.38
EHMT1 Q9H9B1 3/20 0.38
EZH2 Q15910 1/20 0.38
CASP1 P29466 1/20 0.37
CASP5 P51878 1/20 0.37
ACHE P22303 1/20 0.36
BACE1 P56817 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.36
NPC1 O15118 1/20 0.36
KDM1A O60341 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2814053 0.88 SIGMAR1 (0.48) DNMT3ACASP1CASP5ALDH1A1LMNA
SCHEMBL2809639 0.88 SIGMAR1 (0.48) DNMT3ACASP1CASP5ALDH1A1LMNA
SCHEMBL2810802 0.84 CASP1 (0.43) CASP1CASP5ALDH1A1LMNAHTT
SCHEMBL2810498 0.83 DNMT3A (0.44) DNMT3ACASP1CASP5ALDH1A1LMNA
SCHEMBL2809502 0.83 HTR6 (0.41) EHMT2NSD2NSD3EHMT1EZH2
SCHEMBL2813108 0.83 NTSR1 (0.43) MAPK1HTR1AHTR3A
SCHEMBL2812365 0.82 DRD4 (0.39) DNMT3ACASP1CASP5ALDH1A1HTT
SCHEMBL537792 0.82 SIGMAR1 (0.46) CASP1CASP5ALDH1A1HTTSMN1; SMN2
SCHEMBL2810547 0.82 KDM4E (0.43) CASP1CASP5ACHEUSP2ALDH1A1
SCHEMBL2809650 0.81 ALDH1A1 (0.40) ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 EHMT2 3441/4885DNMT3A 2966/4885NSD2 1225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.